The recent progress in our understanding of how some proteins can recognize inositol lipids via specific binding domains, such as pleckstrin homology (PH) domains, has been put to a good practical use to measure these lipids in live cells in real time. But what are the limitations, and what are the ways forward?
during chemotaxis of macrophages or Dictyostelium there is extensive polarisation of the enzymes that synthesize and remove PtdIns(3,4,5)P 3 , and this has been shown to be reflected by a gradient of the lipid itselfrevealed by a tagged PtdIns(3,4,5)P 3 -specific PH domain [5] .
However (and if there wasn't a however, I wouldn't be writing this), over the last few years a few complications have arisen, and a new and complementary approach to using these inositol lipid probes is beginning to emerge. For example, the use of the PH domain from PI-PLC δ δ 1 to measure PtdIns(4,5)P 2 is markedly compromised by the fact that, as part of a feedback-inhibition loop, the product of PtdIns(4,5)P 2 hydrolysis, Ins(1,4,5)P 3 , competes very effectively with PtdIns(4,5)P 2 for the PH domain [6] . So, simply put, if the PI-PLC δ δ 1 PH domain falls off the plasma membrane, we do not know if it is because PtdIns(4,5)P 2 decreases or Ins(1,4,5)P 3 increases, or both.
Hirose et al. [7] have used this competition by Ins(1,4,5)P 3 as an elegant single cell assay for Ins(1,4,5)P 3 production, and validated it by showing that increasing Ins(1,4,5)P 3 -5-phosphatase levels by transfection prevents the PH domain falling off the plasma membrane. This finding essentially means that the increase in Ins(1,4,5)P 3 (and not the decrease in PtdIns(4,5)P 2 ) must be the major factor regulating the localisation of the PH domain, at least in those cells. This has led to some controversy regarding whether or not this is true for all cells (for example, see [8] ), but I suspect that the most likely answer is that the localisation of this domain is usually regulated by a mechanism that depends on the levels of both phosphoinositides -that is, the more the PtdIns(4,5)P 2 decreases, the better the Ins (1,4,5 the answer, this issue does complicate any attempt to quantify the actual levels of PtdIns(4,5)P 2 in real time.
In addition, there is another problem with all these experiments, and that is that the probe only reveals what it can 'see'. That the PH domain of PI-PLC δ δ 1 lights up the plasma membrane almost exclusively in most cells is itself puzzling, given that we know there is plenty of PtdIns(4,5)P 2 elsewhere, for example in the Golgi, in endosomes and in the nucleus. It is in these places that some of the 'proliferation of functions' of PtdIns(4,5)P 2 has occurred, and this reveals the 'catch-22' of these probes: if PtdIns(4,5)P 2 is functional, it must be interacting with something, and this must be via its headgroup (or it would not be specific); and if it is interacting with that something, it cannot simultaneously interact with the PH domain that is supposed to 'see' it. So, unless there is a significant excess of PtdIns(4,5)P 2 in a given location, PtdIns(4,5)P 2 may not be visible to the probe, and this may indeed be true in most parts of the cell other than in the plasma membrane, where there is usually plenty of 'spare' PtdIns(4,5)P 2 for the PIPLCs and the PI 3-kinases to use as substrate. An increase in 'free' PtdIns(4,5)P 2 in intracellular compartments has been detected using the PI-PLC δ δ 1 PH domain by Aikawa et al. [9] , but this can only be semiquantitative, and perhaps it tells us no more than that there are more PtdIns(4,5)P 2 molecules inside the cell with their headgroups exposed.
A recent and elegant way around these problems is to use these probes on fixed tissue, just like an antibody. Antibodies to PtdIns(4,5)P 2 and PtdIns(3,4)P 2 are available, and these have been used to reveal, for example, the localisation of these lipids in the nucleus [10, 11] . However, there are five other polyphosphoinositol lipids, and we still know very little about several of these, especially their distribution within the cell. Thus the recent use of PH domains in electron microscopy on fixed tissues by Jean Lucocq and Pete Downes' groups [12, 13] , is an especially enticing and complementary approach. Their first sally used our old friend the PH domain of PI-PLCδ δ 1 [12] , and the difference between these results and those obtained with live cells as discussed above encapsulates the relative strengths and weaknesses of the two approaches. Carrying out electron microscopy on fixed tissues requires a lot more work, and there is no real-time readout. But you do, for the first time, get real quantification of PtdIns(4,5)P 2 , and you get it in all parts of the cell (and all in the same sample).
Watt et al. [13] have now extended this approach to PtdIns(3,4)P 2 , an inositol lipid of considerable interest to cell signallers, but about which we know very little (and absolutely nothing about how much is where in the cell). This group used the PH domain of TAPP1, which is very specific in its interaction with PtdIns(3,4)P 2 . Indeed, the structural details of this interaction [14] , and the elucidation of why TAPP binds only PtdIns(3,4)P 2 , and not PtdIns(4,5)P 2 nor PtdIns(3,4,5)P 3 , is an example of how we can understand the way in which biology tinkers with the sequence of a multi-functional domain to get exquisite structural specificity. Watt et al. [13] have now used this domain to show that, although PtdIns(3,4)P 2 is mostly in the plasma membrane, it is also found elsewhere in the cell, such as in multivesicular bodies and the nucleus. Interestingly, the levels of PtdIns(3,4)P 2 seem to be regulated differently in these locationstreatment with platelet-derived growth factor (PDGF) or hydrogen peroxide affects PtdIns(3,4)P 2 levels in multivesicular bodies but not in the nucleus.
Despite the caveats discussed above, there is still a huge amount we can and will learn about these and other inositol lipids by using these probes in living cells, especially as more specific binding domains are brought into play. However, the expansion of the use of these probes into electron microscopy of fixed sections is clearly something that needs to take place in parallel because of the respective merits of the two approaches. There are exciting times ahead. 
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